The poll included a national sample of 1,007 adults. It was conducted April 18-21, before the FDA and CDC lifted the pause on Johnson & Johnson’s vaccine in the U.S.
Five poll findings:
1. Seventy-three percent of the 369 unvaccinated Americans surveyed said they were not willing to get the Johnson & Johnson vaccine.
2. Seventy-three percent of all survey participants said they believed the Pfizer vaccine is “very” or “somewhat” safe. Seventy-one percent said the same of the Moderna vaccine, but only 46 percent said they believed the Johnson & Johnson vaccine was “very” or “somewhat” safe.
3. Fifty-six percent of survey participants had already received at least one vaccine dose.
4. Among the 44 percent of unvaccinated survey participants, 16 percent said they would definitely not get vaccinated, and 8 percent said they will probably not get vaccinated.
5. Fifty-five percent of survey participants said they believed the pandemic is only somewhat under control, and 28 percent said they believed it is completely or mostly controlled.
Learn more about the poll here.
More articles on leadership and management:
Departing Mass General president on preserving hospital’s culture, setting new benchmarks
Ball back in Democrats’ court after Biden’s CMS nomination delayed
Top medical schools report surges in applications, changes in strategy after pandemic
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
